Pharmacology of personalised and targeted drugs
-
Chair(s):
Meiyu Geng,
Professor and Academic Director, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China -
Session description:
PTEN status determines the chemosensitivity to proteasome inhibition in cholangiocarcinoma
Professor Hongyang Wang
Professor and Director, National Center for Liver Cancer, Shanghai, ChinaProteome activity landscapes of tumor cell lines determine drug responses
Professor Bernhard Kuster
Professor and Chair, Technische Universitaet Muenchen, Freising, GermanyOral communication speaker - to be confirmed in 2023.
Transcriptomics for individualized cancer therapy with natural products
Professor Thomas Efferth
Institute of Pharmacy and Biomedical Sciences, Johannes Gutenberg University, Mainz,
GermanyPersonalized medicine in Alzheimer's disease
Professor. Meiyu Geng
Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
Speakers
-
Professor Bernhard KusterProfessor and Chair, Technische Universitaet Muenchen, Freising, Germany
-
Professor Hongyang WangProfessor and Director, National Center for Liver Cancer, Shanghai, China
-
Professor Meiyu GengShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China
-
Professor Thomas EfferthInstitute of Pharmacy and Biomedical SciencesJohannes Gutenberg University, Mainz, Germany; Department of Pharmaceutical Biology, Mainz University, Mainz, Germany
Leave A Comment